Akebia Therapeutics Inc (AKBA)

Dec 21, 2024

404,718 Shares in Akebia Therapeutics, Inc. (NASDAQ:AKBA) Acquired by Wellington Management Group LLP - MarketBeat

Dec 21, 2024

Dec 20, 2024

High Growth Tech Stocks To Watch In December 2024 - Simply Wall St

Dec 20, 2024

Dec 20, 2024

Investors in Akebia Therapeutics (NASDAQ:AKBA) have unfortunately lost 73% over the last five years - Yahoo Finance

Dec 20, 2024

Dec 19, 2024

Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Eastern Progress Online

Dec 19, 2024

Dec 19, 2024

CMS Grants TDAPA Reimbursement for Vafseo® (vadadustat) beginning January 1, 2025 - The Eastern Progress Online

Dec 19, 2024

Dec 15, 2024

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listi - GuruFocus.com

Dec 15, 2024

Dec 13, 2024

Akebia Therapeutics (NASDAQ:AKBA) Upgraded by StockNews.com to Hold Rating - MarketBeat

Dec 13, 2024

Dec 12, 2024

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Eastern Progress Online

Dec 12, 2024

Dec 11, 2024

Akebia Therapeutics to Present at the Jefferies London Healthcare Conference - The Eastern Progress Online

Dec 11, 2024

Dec 08, 2024

Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference - Kilgore News Herald

Dec 08, 2024

Dec 07, 2024

Akebia Therapeutics to Present at Upcoming Investor Conferences - The Eastern Progress Online

Dec 07, 2024

Dec 05, 2024

New Strong Sell Stocks for December 5th - Yahoo Finance

Dec 05, 2024

Dec 04, 2024

Akebia Therapeutics (FRA:AX9) EBITDA : €4.0 Mil (TTM As of Sep. 2024) - GuruFocus.com

Dec 04, 2024

Dec 03, 2024

U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis - Longview News-Journal

Dec 03, 2024

Dec 03, 2024

Akebia Therapeutics Awards 121,000 Stock Options to New Employees in Retention Push - StockTitan

Dec 03, 2024

Nov 29, 2024

Biotech Alert: Searches spiking for these stocks today - TipRanks

Nov 29, 2024

Nov 27, 2024

New Strong Sell Stocks for November 27th - Yahoo Finance

Nov 27, 2024

Nov 23, 2024

Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GuruFocus.com

Nov 23, 2024

Nov 23, 2024

Vadadustat Alternative Dosing Study Results Published in the Ame - GuruFocus.com

Nov 23, 2024

Nov 23, 2024

AKBA (Akebia Therapeutics) Future 3-5Y Total Revenue Growth Rate : 9.95 (As of Nov. 23, 2024) - GuruFocus.com

Nov 23, 2024

Nov 22, 2024

Akebia Therapeutics to Report Third Quarter 2024 Financial Resul - GuruFocus.com

Nov 22, 2024

Nov 22, 2024

Akebia Therapeutics and U.S. Renal Care Sign Commercial Supply C - GuruFocus.com

Nov 22, 2024

Nov 22, 2024

Akebia Therapeutics Announces Seven Poster Presentations at ASN Kidney Week 2024 - GuruFocus.com

Nov 22, 2024

Nov 20, 2024

Q3 2024 Earnings: Hold Akebia Therapeutics (NASDAQ:AKBA) - Seeking Alpha

Nov 20, 2024

Nov 14, 2024

Akebia's FDA-Approved Vafseo Shows Promise in Key Dialysis Trial Results | AKBA Stock News - StockTitan

Nov 14, 2024

Nov 14, 2024

Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease - Longview News-Journal

Nov 14, 2024

Nov 13, 2024

Akebia Therapeutics (NASDAQ:AKBA) Stock Rating Lowered by StockNews.com - Defense World

Nov 13, 2024

Nov 09, 2024

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024

Nov 09, 2024

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50 - Yahoo Finance

Nov 09, 2024

Nov 08, 2024

Earnings call: Akebia reports Q3 results, gears up for Vafseo launch - Investing.com Australia

Nov 08, 2024

Nov 08, 2024

Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Price Is Right But Growth Is Lacking After Shares Rocket 41% - Simply Wall St

Nov 08, 2024

Nov 08, 2024

Akebia Therapeutics Inc (AKBA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ... By GuruFocus - Investing.com Canada

Nov 08, 2024

Nov 08, 2024

Akebia Therapeutics Inc (AKBA) Q3 2024 Earnings Call Highlights: - GuruFocus.com

Nov 08, 2024

Nov 08, 2024

Akebia Therapeutics Inc (AKBA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

Akebia Therapeutics: Q3 Earnings Snapshot - CT Insider

Nov 08, 2024

Nov 08, 2024

Akebia Therapeutics Prepares for Vafseo Launch - TipRanks

Nov 08, 2024